Update Informed Consent and Education Be clear if the med is FDA-approved or compounded Discuss risks and side effects Set expectations for follow-up Tell patients what to do if they have symptoms Have your consent language reviewed by a compliance expert Audit Website, Ads, and Social Check every channel (website, ads, email, SMS, booking, etc.) Delete language that misleads patients about compounded meds being FDA-approved or uses brand names wrong
A short pause can teach you more than a long restriction
BjrnholmKDSkovstedGFMitgaard-ThomsenARakipovskiGTveden-NyborgPLykkesfeldtJet alLiraglutide treatment improves endothelial function in the ldlr-/- mouse model of atherosclerosis and affects genes involved in vascular remodelling and inflammation
Tirzepatide: A Versatile Active Ingredient Tirzepatide, the active ingredient in Zepbound, is already making strides under the trade name Mounjaro for improving blood glucose in adults with type 2 diabetes mellitus
All products sold by Solira are for laboratory and research purposes only